HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Very early combination antiretroviral therapy in infants: prospects for cure.

AbstractPURPOSE OF REVIEW:
A single case of sustained HIV control in the absence of antiretroviral therapy or HIV-specific immune responses ensued following 18 months of combination antiretroviral therapy initiated at 30 h of age in a perinatally HIV-infected child (the Mississippi child). This case provides proof-of-concept that delay in HIV viremic rebound may ensue following very early treatment (VET) in perinatal infection, likely through marked reduction of latent replication-competent HIV reservoirs.
RECENT FINDINGS:
The latent HIV reservoir remains the critical barrier to remission. Several studies indicate that the earlier effective combination antiretroviral therapy is initiated, the smaller the size of the HIV reservoir. The unique ability of perinatally infected neonates to initiate VET at the time of birth maximizes the potential benefits of limiting latent reservoir size and permitting reservoir decay, likely lengthening the duration of remission and limiting the capacity for re-establishment of viremia.
SUMMARY:
This article covers the rationale and feasibility of VET to achieve sustained virologic remission in perinatal infection. Recent studies highlighting the effects of VET on biomarkers of HIV persistence in perinatal HIV infection are reviewed as well as implications and challenges for cure research in pediatric populations.
AuthorsKaitlin Rainwater-Lovett, Katherine Luzuriaga, Deborah Persaud
JournalCurrent opinion in HIV and AIDS (Curr Opin HIV AIDS) Vol. 10 Issue 1 Pg. 4-11 (Jan 2015) ISSN: 1746-6318 [Electronic] United States
PMID25402708 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Anti-HIV Agents
Topics
  • Anti-HIV Agents (administration & dosage)
  • Antiretroviral Therapy, Highly Active
  • Female
  • HIV Infections (drug therapy, prevention & control, transmission)
  • HIV-1
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical (prevention & control)
  • Pregnancy
  • Pregnancy Complications, Infectious

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: